Express Scripts settled the insulin case without paying a cent or admitting a thing.

By ··1 min read·3 sources

The FTC's order changes how Cigna's pharmacy benefit manager behaves from here. It returns nothing for the years the agency says list prices were inflated.

The FTC sued Express Scripts, CVS Caremark and Optum Rx in September 2024. It said the three, which handle about 80% of U.S. prescriptions, pushed drugmakers to compete on the size of the rebate, not on price, and kept a share. Patients whose cost-sharing tracked list price paid the difference.

The February 4, 2026 consent order sets real conduct terms. Express Scripts' standard offering can no longer favor a high-list-price drug over an identical cheaper version. Its pay from manufacturers is delinked from list price. Community pharmacies move to cost-plus reimbursement, and its Swiss rebate aggregator, Ascent, comes back to the United States.

Those terms are also the whole remedy. The deal carries no monetary penalty and no admission of wrongdoing, and Express Scripts has until 2027 to comply with most of it. The FTC's headline figure, up to $7 billion in patient savings over 10 years, is a forecast. Nobody is being repaid.

The pattern has repeated. Caremark settled on similar terms in July, and Optum Rx reached a tentative deal in June. The largest enforcement action ever brought against PBMs is ending without a fine, a finding or a refund. The order rewrites the rules going forward and counts a projection as the win.

Sources

  1. ftc.gov · ftc.gov/news-events/news/press-releases/2026/02/ftc-secures-landmark-settlement-express-sc…
  2. biopharmadive.com · biopharmadive.com/news/express-scripts-ftc-reach-settlement-insulin-lawsuit/811436/
  3. healthcaredive.com · healthcaredive.com/news/unitedhealth-optum-rx-ftc-proposed-settlement-insulin-case/822857/

Cite this report

The Precedent. "Express Scripts settled the insulin case without paying a cent or admitting a thing.." October 8, 2026. https://theprecedent.org/article/express-scripts-settled-the-insulin-case-without-paying-a-cent-or-admitting-a-th

Companies in this report